hiv - Search News

News

AIDS, HIV and Senate

BBC on MSN · 1h

US senators exempt HIV/Aids funding from planned spending cuts

Republicans in the US Senate have said they will spare the US-backed HIV/Aids programme Pepfar from cuts, amid a larger effort to reduce government spending. Senators said they would end a plan to cut $400m (£300m) from the President's Emergency Plan for Aids Relief programme, leaving total proposed cuts at $9bn.

Fox News on MSN · 18h

Senate GOP agree to strip cuts to HIV, AIDS prevention program from Trump's clawback bill

Republicans plan to strip $400 million in global AIDS program cuts from President Donald Trump's rescission package, as Sen. John Thune plows forward before funding holds expire.

Republicans Scrap Plan to Cut $400 Million From PEPFAR Anti-AIDS Program

The deal would shield PEPFAR from the Trump Administration’s plan to cancel billions in previously approved but unspent federal funds. The decision came after several Republican senators objected to including the widely celebrated HIV/AIDS initiative in a list of programs targeted for clawbacks under Trump’s campaign to root out what he has called “waste,

2don MSN

WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

IAS 2025: All eyes still on the HIV reservoir

While people living with HIV can lead virtually normal lives thanks to antiretroviral therapy (ART), HIV persists in a latent ...

1don MSN

WHO recommends Gilead's twice-yearly injection for HIV prevention

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

21h

HIV prevention gets an AI upgrade

Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...

The American Journal of Managed Care55m

Most Patients With HIV Opted for Injectable ART, PrEP in Phase 3 Trial

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

12hon MSN

New Study Shows How Providers Can Use Apretude To Prevent And Treat HIV In Black Women

A new study explores how healthcare providers can effectively implement Apretude for HIV pre-exposure prophylaxis (PrEP) ...

1don MSN

ViiV expands licence to allow generic HIV treatment production for low-income countries

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

5h

Loss of $4M grant threatens HIV prevention efforts in Tennessee

This story was originally published by The Institute for Public Service Reporting Memphis. Healthcare providers across ...

ViiV expands licensing deal for its HIV drug in low-income countries

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

Are UC researchers any closer to finding a functional cure for HIV?

This 2011 electron microscope image made available by the Centers for Disease Control shows HIV virions. On Wednesday, Sept.

Standard HIV treatment may cause bone, kidney harm in older persons – research

Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results